Focus on Nintedanib in NSCLC and Other Tumors

Nintedanib is a new triple angiokinase inhibitor that potently blocks the proangiogenic pathways mediated by vascular endothelial growth factor receptors, platelet-derived growth factor receptors, and fibroblast growth factor receptors. Evidence about its efficacy in addition to second-line chemothe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Med (Lausanne)
Hoofdauteurs: Manzo, Anna, Carillio, Guido, Montanino, Agnese, Costanzo, Raffaele, Sandomenico, Claudia, Rocco, Gaetano, Morabito, Alessandro
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2016
Onderwerpen:
Medicine
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5165233/
https://ncbi.nlm.nih.gov/pubmed/28066768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2016.00068
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items